The gut-immune-brain axis in neurodevelopment and neurological disorders

Microbiome Res Rep. 2022 Aug 17;1(4):23. doi: 10.20517/mrr.2022.11. eCollection 2022.

Abstract

The gut-brain axis is gaining momentum as an interdisciplinary field addressing how intestinal microbes influence the central nervous system (CNS). Studies using powerful tools, including germ-free, antibiotic-fed, and fecal microbiota transplanted mice, demonstrate how gut microbiota perturbations alter the fate of neurodevelopment. Probiotics are also becoming more recognized as potentially effective therapeutic agents in alleviating symptoms of neurological disorders. While gut microbes may directly communicate with the CNS through their effector molecules, including metabolites, their influence on neuroimmune populations, including newly discovered brain-resident T cells, underscore the host immunity as a potent mediator of the gut-brain axis. In this review, we examine the unique immune populations within the brain, the effects of the gut microbiota on the CNS, and the efficacy of specific probiotic strains to propose the novel concept of the gut-immune-brain axis.

Keywords: Alzheimer’s disease; Gut-brain axis; autism spectrum disorder; blood-brain barrier; microbiota; neuroimmunology; neuroinflammation; probiotics.

Publication types

  • Review